{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:13:14Z","timestamp":1778004794014,"version":"3.51.4"},"reference-count":42,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,11,8]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>The PERSEIDS study aimed to estimate incidence\/prevalence of interstitial lung diseases (ILDs), fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and their progressive-fibrosing (PF) forms in six European countries, as current data are scarce.<\/jats:p><jats:p>This retrospective, two-phase study used aggregate data (2014\u20132018). In Phase 1, incident\/prevalent cases of ILDs above were identified from clinical databases through an algorithm based on codes\/keywords, and incidence\/prevalence was estimated. For non-IPF F-ILDs, the relative percentage of subtypes was also determined. In Phase 2, a subset of non-IPF F-ILD cases was manually reviewed to determine the percentage of PF behaviour and usual interstitial pneumonia-like (UIP-like) pattern. A weighted mean percentage of progression was calculated for each country and used to extrapolate incidence\/prevalence of progressive-fibrosing ILDs (PF-ILDs).<\/jats:p><jats:p>In 2018, incidence\/10<jats:sup>5<\/jats:sup>person-years ranged between 9.4 and 83.6 (ILDs), 7.7 and 76.2 (F-ILDs), 0.4 and 10.3 (IPF), 6.6 and 71.7 (non-IPF F-ILDs), and 0.3 and 1.5 (SSc-ILD); and prevalence\/10<jats:sup>5<\/jats:sup>persons ranged between 33.6 and 247.4 (ILDs), 26.7 and 236.8 (F-ILDs), 2.8 and 31.0 (IPF), 22.3 and 205.8 (non-IPF F-ILDs), and 1.4 and 10.1 (SSc-ILD). Among non-IPF F-ILDs, sarcoidosis was the most frequent subtype. PF behaviour and UIP-like pattern were present in a third of non-IPF F-ILD cases each and hypersensitivity pneumonitis showed the highest percentage of progressive behaviour. Incidence of PF-ILDs ranged between 2.1 and 14.5\/10<jats:sup>5<\/jats:sup>person-years, and prevalence between 6.9 and 78.0\/10<jats:sup>5<\/jats:sup>persons.<\/jats:p><jats:p>To our knowledge, PERSEIDS is the first study assessing incidence, prevalence and rate of progression of ILDs across several European countries. Still below the threshold for orphan diseases, the estimates obtained were higher and more variable than reported in previous studies, but differences in study design\/population must be considered.<\/jats:p>","DOI":"10.1183\/23120541.00597-2021","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T13:01:07Z","timestamp":1638450067000},"page":"00597-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries"],"prefix":"10.1183","volume":"8","author":[{"given":"Ole","family":"Hilberg","sequence":"first","affiliation":[]},{"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-0765","authenticated-orcid":false,"given":"Demosthenes","family":"Bouros","sequence":"additional","affiliation":[]},{"given":"Maritta","family":"Kilpel\u00e4inen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-1730","authenticated-orcid":false,"given":"Julien","family":"Guiot","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-8651","authenticated-orcid":false,"given":"Antonio","family":"Morais","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Clemente","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Daniil","sequence":"additional","affiliation":[]},{"given":"Despina","family":"Papakosta","sequence":"additional","affiliation":[]},{"given":"Havard","family":"Fretheim","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Neves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6490-0620","authenticated-orcid":false,"given":"Tiago M.","family":"Alfaro","sequence":"additional","affiliation":[]},{"given":"Katerina M.","family":"Antoniou","sequence":"additional","affiliation":[]},{"given":"Neus","family":"Valveny","sequence":"additional","affiliation":[]},{"given":"Guus","family":"Asijee","sequence":"additional","affiliation":[]},{"given":"St\u00e9phane","family":"Soulard","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9648-3497","authenticated-orcid":false,"given":"Wim","family":"Wuyts","sequence":"additional","affiliation":[]},{"name":"the PERSEIDS study group","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[]},{"given":"Vassilios","family":"Tzilas","sequence":"additional","affiliation":[]},{"given":"Argyris","family":"Tzouvelekis","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Bouros","sequence":"additional","affiliation":[]},{"given":"Katariina","family":"Perkonoja","sequence":"additional","affiliation":[]},{"given":"Monique","family":"Henket","sequence":"additional","affiliation":[]},{"given":"Marie-Pierre","family":"Cunin","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Mart\u00edn","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Branco","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Alvarenga","sequence":"additional","affiliation":[]},{"given":"Ilias","family":"Dimeas","sequence":"additional","affiliation":[]},{"given":"Theodora","family":"Simopoulou","sequence":"additional","affiliation":[]},{"given":"Evangelia","family":"Fouka","sequence":"additional","affiliation":[]},{"given":"Ioanna","family":"Tsiouprou","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Zaharias","sequence":"additional","affiliation":[]},{"given":"Sergio","family":"Campainha","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"V\u00e2nia","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Cabo","sequence":"additional","affiliation":[]},{"given":"Irini","family":"Vasarmidi","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2024101711253028000_8.1.00597-2021.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2024101711253028000_8.1.00597-2021.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2024101711253028000_8.1.00597-2021.3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12931-019-1020-3","article-title":"The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry","volume":"20","author":"Kreuter","year":"2019","journal-title":"Respir Res"},{"key":"2024101711253028000_8.1.00597-2021.4","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00172-2019"},{"key":"2024101711253028000_8.1.00597-2021.5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2018"},{"key":"2024101711253028000_8.1.00597-2021.6","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1007\/s12325-020-01384-0","article-title":"The burden of progressive fibrosing interstitial lung disease: a DELPHI approach","volume":"37","author":"Wuyts","year":"2020","journal-title":"Adv Ther"},{"key":"2024101711253028000_8.1.00597-2021.7","doi-asserted-by":"crossref","first-page":"e0163894","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS ONE"},{"key":"2024101711253028000_8.1.00597-2021.8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711253028000_8.1.00597-2021.9","doi-asserted-by":"crossref","unstructured":"Hoffmann-Vold A-M , Bendstrup E , Dimitroulas T , et al. Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews. Rheumatology (Oxford) 2021; 60: 5601\u20135609. doi:10.1093\/rheumatology\/keab154","DOI":"10.1093\/rheumatology\/keab154"},{"key":"2024101711253028000_8.1.00597-2021.10","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0077-2018"},{"key":"2024101711253028000_8.1.00597-2021.11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","article-title":"Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician Survey","volume":"38","author":"Olson","year":"2021","journal-title":"Adv Ther"},{"key":"2024101711253028000_8.1.00597-2021.12","unstructured":"Danish Health Authority (Sundhedsstyrelsen) . Researcher machine. 2019. https:\/\/sundhedsdatastyrelsen.dk\/da\/forskerservice\/forskermaskinen Date last accessed: 3 July 2020."},{"key":"2024101711253028000_8.1.00597-2021.13","unstructured":"Auria Clinical Informatics . For researchers. 2020. www.auria.fi\/tietopalvelu\/en\/tutkijalle\/index.html Date last accessed: 3 July 2020."},{"key":"2024101711253028000_8.1.00597-2021.14","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018"},{"key":"2024101711253028000_8.1.00597-2021.15","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2001.026"},{"key":"2024101711253028000_8.1.00597-2021.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.03.001"},{"key":"2024101711253028000_8.1.00597-2021.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-8-24"},{"key":"2024101711253028000_8.1.00597-2021.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.09.002"},{"key":"2024101711253028000_8.1.00597-2021.19","doi-asserted-by":"crossref","unstructured":"Bendstrup E , Hyldgaard C , Altraja A , et al. Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries. Eur Clin Respir J 2015; 2. doi:10.3402\/ecrj.v2.28348","DOI":"10.3402\/ecrj.v2.28348"},{"key":"2024101711253028000_8.1.00597-2021.20","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1093\/rheumatology\/keaa026","article-title":"Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort","volume":"59","author":"Fretheim","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2024101711253028000_8.1.00597-2021.21","unstructured":"E uropean Medicines Agency . Orphan designation: overview. 2020. www.ema.europa.eu\/en\/human-regulatory\/overview\/orphan-designation-overview Date last accessed: 18 December 2020."},{"key":"2024101711253028000_8.1.00597-2021.22","unstructured":"World Health Organization . WHO report on the global tobacco epidemic 2019: offer help to quit tobacco use [Internet]. 2019. www.who.int\/teams\/health-promotion\/tobacco-control\/who-report-on-the-global-tobacco-epidemic-2019 Date last accessed: 2 November 2021."},{"key":"2024101711253028000_8.1.00597-2021.23","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.148031"},{"key":"2024101711253028000_8.1.00597-2021.24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/17476348.2019.1556639","article-title":"The place of high-resolution computed tomography imaging in the investigation of interstitial lung disease","volume":"13","author":"Jeny","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2024101711253028000_8.1.00597-2021.25","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2024101711253028000_8.1.00597-2021.26","unstructured":"Organisation for Economic Co-operation and Development . Peer-review of the Finnish shipbuilding industry [Internet]. 2018. www.oecd.org\/finland\/peer-review-finland-shipbuilding-industry.pdf Date last accessed: 17 December 2020."},{"key":"2024101711253028000_8.1.00597-2021.27","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2006.032284"},{"key":"2024101711253028000_8.1.00597-2021.28","unstructured":"Associa\u00e7ao Portuguesa da Corti\u00e7a . Information bureau 2019. Corti\u00e7a em n\u00fameros. 2018. www.apcor.pt\/wp-content\/uploads\/2019\/02\/CORTI%c3%87A-em-n%c3%bameros_PT.pdf Date last accessed: 18 December 2020."},{"key":"2024101711253028000_8.1.00597-2021.29","unstructured":"Federa\u00e7\u00e3o Portuguesa de Columbofilia . Sobre a Federa\u00e7\u00e3o. 2020. www.fpcolumbofilia.pt\/index.htm Date last accessed: 17 December 2020."},{"key":"2024101711253028000_8.1.00597-2021.30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pulmoe.2018.07.003","article-title":"Hypersensitivity pneumonitis: antigen diversity and disease implications","volume":"25","author":"Nogueira","year":"2019","journal-title":"Pulmonology"},{"key":"2024101711253028000_8.1.00597-2021.31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pulmoe.2019.03.005","article-title":"Is probable usual interstitial pneumonia pattern synonymous with idiopathic pulmonary fibrosis?","volume":"25","author":"Marques","year":"2019","journal-title":"Pulmonology"},{"key":"2024101711253028000_8.1.00597-2021.32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2032ST"},{"key":"2024101711253028000_8.1.00597-2021.33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/resp.13733","article-title":"Twenty-five years of Respirology: advances in idiopathic pulmonary fibrosis","volume":"25","author":"Varone","year":"2020","journal-title":"Respirology"},{"key":"2024101711253028000_8.1.00597-2021.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024101711253028000_8.1.00597-2021.35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02718-2020"},{"key":"2024101711253028000_8.1.00597-2021.36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1159\/000509556","article-title":"Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers","volume":"99","author":"Faverio","year":"2020","journal-title":"Respiration"},{"key":"2024101711253028000_8.1.00597-2021.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217455"},{"key":"2024101711253028000_8.1.00597-2021.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2106012"},{"key":"2024101711253028000_8.1.00597-2021.39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024101711253028000_8.1.00597-2021.40","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0053"},{"key":"2024101711253028000_8.1.00597-2021.41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yacr.2020.04.004","article-title":"Update in imaging of idiopathic pulmonary fibrosis","volume":"2","author":"Kaproth-Joslin","year":"2020","journal-title":"Adv Clin Radiol"},{"key":"2024101711253028000_8.1.00597-2021.42","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00205914"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00597-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:13:11Z","timestamp":1740373991000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00597-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,24]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1183\/23120541.00597-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00597-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}